| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/16/1998 | EP0863866A1 Butyrate prodrugs of lactic acid |
| 09/16/1998 | EP0863752A1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
| 09/16/1998 | EP0863704A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 09/16/1998 | EP0833629A4 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 09/16/1998 | EP0767786B1 7-ether-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
| 09/16/1998 | EP0710230B1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 09/16/1998 | EP0699442B1 Use of a strain of the fungus fusarium as a producer of substances and a preparation based on said substances with adaptogenic and immunomodulating properties |
| 09/16/1998 | EP0554356B1 A monoclonal antibody |
| 09/16/1998 | CN1193313A Propynyl or dienyl diaromatic compounds |
| 09/16/1998 | CN1193280A Control of CD44 gene expression for therapeutic use |
| 09/16/1998 | CN1193278A Chemical compounds |
| 09/16/1998 | CN1193022A Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 09/16/1998 | CN1192910A Oral liquor for treatment of lung cancer and preparation method therefor |
| 09/16/1998 | CN1192901A Chemical compound for treating cancer and preparing process thereof |
| 09/15/1998 | US5808137 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumors |
| 09/15/1998 | US5808049 Antitumor |
| 09/15/1998 | US5808047 Blocking; hydrolysis; oxidation |
| 09/15/1998 | US5808033 Family of anti-carcinoembryonic antigen chimeric antibodies |
| 09/15/1998 | US5808030 Polypeptide |
| 09/15/1998 | US5808021 Method for controlling O-desulfation of heparin |
| 09/15/1998 | US5808007 Treating cell proliferative or immunologic disorders |
| 09/15/1998 | US5808005 Medical diagnosis; vaccines |
| 09/15/1998 | US5807886 Treatment of neurodegenerative disorders, migraine, drug addiction |
| 09/15/1998 | US5807884 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 09/15/1998 | US5807882 Anthracene compounds useful in treating certain cancers |
| 09/15/1998 | US5807876 Inosine-5'-monophospate dehydrogenase; viral diseases, cancer, vascular diseases; merimepodib |
| 09/15/1998 | US5807862 Therapeutic compounds containing pyrimidinyl moieties |
| 09/15/1998 | US5807853 Tricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseases |
| 09/15/1998 | US5807852 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 09/15/1998 | US5807836 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 09/15/1998 | US5807835 Antitumor agents |
| 09/15/1998 | US5807826 Semaphorin gene family |
| 09/15/1998 | US5807818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products |
| 09/15/1998 | US5807744 Incubation; separation of bone marrow and tumor cells |
| 09/15/1998 | US5807731 Antitumor |
| 09/15/1998 | US5807692 P21WAF1 derivatives and diagnostic methods |
| 09/15/1998 | US5807559 Compositions for generating T cell immunity against carbohydrate structures |
| 09/15/1998 | US5807548 Method of treating cancer using a chimera antibody |
| 09/15/1998 | CA2122815C 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof |
| 09/14/1998 | CA2231917A1 Promoter of the cdc25b gene, its preparation and use |
| 09/14/1998 | CA2221830A1 Tumor necrosis factor related receptor, tr6 |
| 09/13/1998 | CA2231765A1 Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures |
| 09/11/1998 | WO1998039659A1 Screening and treatment using complement regulator or receptor proteins |
| 09/11/1998 | WO1998039465A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 09/11/1998 | WO1998039464A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 09/11/1998 | WO1998039449A1 COMPOSITIONS AND USE OF M-CSF-alpha |
| 09/11/1998 | WO1998039443A1 Spα: A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO |
| 09/11/1998 | WO1998039435A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 09/11/1998 | WO1998039430A1 Methods and compositions for diagnosis and treatment of cancer |
| 09/11/1998 | WO1998039429A2 Compositions for treatment of disorders involving programmed cell death |
| 09/11/1998 | WO1998039352A1 Novel bicyclonucleoside and oligonucleotide analogues |
| 09/11/1998 | WO1998039332A1 2-aryl-naphthyridin-4-ones as antitumor agents |
| 09/11/1998 | WO1998039329A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | WO1998039323A1 Anti-mitotic agents which inhibit tubulin polymerization |
| 09/11/1998 | WO1998039292A1 20-epi-22(r)-lower alkyl-substituted vitamin d derivatives and calcium metabolism improving agents containing the same as the active ingredient |
| 09/11/1998 | WO1998039037A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 09/11/1998 | WO1998039033A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
| 09/11/1998 | WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/11/1998 | WO1998039030A1 Vaccine composition for preventing or treating c hepatitis |
| 09/11/1998 | WO1998039024A1 Selective mmp inhibitors having reduced side-effects |
| 09/11/1998 | WO1998039010A1 Tricyclic and tetracyclic pyrones |
| 09/11/1998 | WO1998039009A1 Method of treating a tumor |
| 09/11/1998 | WO1998039006A1 Troglitazone compounds for treating climacteric |
| 09/11/1998 | WO1998038993A1 Method of suppressing tumor growth with combinations of isoprenoids and statins |
| 09/11/1998 | WO1998038984A2 Formulations for hydrophobic pharmaceutical agents |
| 09/11/1998 | WO1998038862A1 6-halo-or nitrate-substituted paclitaxels |
| 09/11/1998 | WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | WO1998031795A3 Novel human metallothionein |
| 09/11/1998 | WO1998030687A3 Protein containing an srcr domain |
| 09/11/1998 | WO1998030584A3 Secreted proteins and polynucleotides encoding them |
| 09/11/1998 | WO1998030190A3 Colon cancer KH-1 and N3 antigens |
| 09/11/1998 | WO1998025956A3 Human GTP-binding proteins |
| 09/11/1998 | WO1998020135A3 Protease-activatable pseudomonas exotoxin a-like proproteins |
| 09/11/1998 | WO1998016238A3 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 09/11/1998 | CA2614782A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 09/11/1998 | CA2285405A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2283791A1 Troglitazone compounds for treating climacteric |
| 09/11/1998 | CA2283471A1 Anti-mitotic agents which inhibit tubulin polymerization |
| 09/11/1998 | CA2283394A1 Methods and compositions for diagnosis and treatment of cancer |
| 09/11/1998 | CA2283333A1 Method of suppressing tumor growth with combinations of isoprenoids and statins |
| 09/11/1998 | CA2283300A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
| 09/11/1998 | CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 09/11/1998 | CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 09/11/1998 | CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 09/11/1998 | CA2283076A1 Vaccine composition for preventing or treating c hepatitis |
| 09/11/1998 | CA2282830A1 Sp.alpha.: a scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto |
| 09/11/1998 | CA2282408A1 6-halo-or nitrate-substituted paclitaxels |
| 09/11/1998 | CA2282399A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 09/11/1998 | CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 09/11/1998 | CA2281484A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 09/11/1998 | CA2280134A1 Selective mmp inhibitors having reduced side-effects |
| 09/10/1998 | DE19711503C1 Pharmazeutische Zusammensetzung zur Aufhebung der membranvermittelten Resistenz von Zellen A pharmaceutical composition for the abolition of membrane-mediated resistance of cells |
| 09/09/1998 | EP0862740A1 Oncogene fusion protein peptide vaccines |
| 09/09/1998 | EP0862634A1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 09/09/1998 | EP0862630A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/09/1998 | EP0862626A1 Pilosulin 2 |
| 09/09/1998 | EP0862578A1 Actinomycin d analogues |
| 09/09/1998 | EP0862564A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 09/09/1998 | EP0862563A1 10-deacetyl-14beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and formulations containing them |
| 09/09/1998 | EP0862559A1 Novel fluorinated or hydroxylated phenylimidazolidines having anti-androgenic activity, method for preparing same, resulting intermediates, and pharmaceutical compositions |